A detailed history of Clear Street Markets LLC transactions in Argenx Se stock. As of the latest transaction made, Clear Street Markets LLC holds 1,474 shares of ARGX stock, worth $831,675. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,474
Previous 1,639 10.07%
Holding current value
$831,675
Previous $175,000 296.0%
% of portfolio
0.18%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$434.22 - $551.9 $71,646 - $91,063
-165 Reduced 10.07%
1,474 $693,000
Q2 2024

Jul 26, 2024

SELL
$356.01 - $451.55 $218,234 - $276,800
-613 Reduced 27.22%
1,639 $175,000
Q1 2024

May 13, 2024

BUY
$356.95 - $413.29 $803,851 - $930,729
2,252 New
2,252 $887,000
Q3 2023

Nov 13, 2023

BUY
$369.35 - $548.43 $703,981 - $1.05 Million
1,906 Added 1906.0%
2,006 $986,000
Q2 2023

Aug 14, 2023

BUY
$360.14 - $422.58 $36,014 - $42,258
100 New
100 $39,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.